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Abstract
Objective—Velo-cardio-facial syndrome (VCFS) is caused by a microdeletion of approximately
40 genes from one copy of chromosome 22. Expression of the syndrome is a variable combination
of over 190 phenotypic characteristics. As of yet, little is known about how these phenotypes
correlate with one another or whether there are predictable patterns of expression. Two of the most
common phenotypic categories, congenital heart disease and cleft palate, have been proposed to
have a common genetic relationship to the deleted T-box 1 gene (TBX1). The purpose of this study
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is to determine if congenital heart disease and cleft palate are correlated in a large cohort of human
subjects with VCFS.
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Methods—This study is a retrospective chart review including 316 Caucasian non-Hispanic
subjects with FISH or CGH microarray confirmed chromosome 22q11.2 deletions. All subjects
were evaluated by the interdisciplinary team at the Velo-Cardio-Facial Syndrome International
Center at Upstate Medical University, Syracuse, NY. Each combination of congenital heart
disease, cleft palates, and retrognathia was analyzed by chi square or Fisher exact test.
Results—For all categories of congenital heart disease and cleft palate or retrognathia no
significant associations were found, with the exception of submucous cleft palate and retrognathia
(nominal p=0.0325) and occult submucous cleft palate and retrognathia (nominal p=0.000013).
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Conclusions—Congenital heart disease and cleft palate do not appear to be correlated in human
subjects with VCFS despite earlier suggestions from animal models. Possible explanations include
modification of the effect of TBX1 by genes outside of the 22q11.2 region that may further
influence the formation of the palate or heart, or the presence of epigenetic factors that may effect
genes within the deleted region, modifying genes elsewhere, or polymorphisms on the normal
copy of chromosome 22. Lastly, it is possible that TBX1 plays a role in palate formation in some
species, but not in humans. In VCFS, retrognathia is caused by an obtuse angulation of the skull
base. It is unknown if the correlation between retrognathia and cleft palate in VCFS indicates a
developmental sequence related to skull morphology, or direct gene effects of both anomalies.
Much work remains to be done to fully understand the complex relationships between phenotypic
characteristics in VCFS.
Keywords
Velo-cardio-facial syndrome; 22q11 deletion; VCFS; cleft palate; submucous cleft palate; occult
submucous cleft palate; retrognathia; TBX1; conotruncal heart anomalies; tetralogy of Fallot;
aortic arch anomalies

Introduction
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Velo-cardio-facial syndrome (VCFS; MIM #192430; [1]) is the most common microdeletion
syndrome in humans with a reported population prevalence of approximately 1:2,000 [2,3].
VCFS is caused by a deletion from one copy of the q11.2 band of chromosome 22 [4,5],
usually about 3 million base pairs containing approximately 40 genes. The deletion results
from meiotic non-allelic homologous recombination events between flanking segmental
duplications also known as low copy repeats [6–8]. VCFS is also known to be the most
frequent syndrome associated with conotruncal heart anomalies and is the most common
multiple anomaly syndrome associated with cleft palate [2,9]. There is a characteristic facial
appearance that can include retrognathia, vertical maxillary excess, vertically long nose with
a bulbous tip, suborbital congestion, hooded upper eyelids, overfolding of the helices and
absent lobules, and occasionally mild hypertelorism. None of these findings occur in all
cases [10]. Previous research using mouse models has suggested that craniofacial and
cardiovascular anomalies may be related to haploinsufficiency of TBX1, a gene mapping to
the deleted 22q11.2 region that encodes a member of the T-box family of transcription
factors [11] and is known to influence the formation of structures associated with the neural
crest [12–14].
To date, research has focused on looking for phenotype to genotype correlations in order to
understand the mechanism for these variably expressed anomalies. One important question
is whether there are genetic modifiers to explain the basis of altered expressivity in affected
individuals. Such genes might be in the same genetic pathway as TBX1 or independent
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pathways. It has been shown for example, that modulating genes such as vascular
endothelial growth factor (VEGF) and fibroblast growth factor (FGF8) can act on the same
pathway as genes from the commonly deleted region at 22q11.2, thereby influencing the
expression of primarily deleted genes such as TBX1 [15,16]. The identification of genetic
modifiers can be guided by the observed correlations between phenotypic expressions. The
question could more specifically ask whether the same modifiers are responsible for varying
phenotypes in different tissues, such as craniofacial and cardiovascular anomalies.
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Because many of the anomalous structures in VCFS are derived from the pharyngeal
apparatus, a temporary embryological structure that forms gills in fish, it may be that much
of the VCFS phenotype represents a series of structures of similar developmental origin, or
“field defects.” It is not clear, however, that this common embryological structure is
sufficient to explain malformations of its derivative structures; field defects can be the result
of any number of factors influencing development of more than one structure. Histological
factors or dysplasias, vascular perfusion, and the effects of gene function at the end stages of
development rather than the primordium all may play an important role in the final
phenotypic presentation. Mechanical and developmental influences instigated by a single
structural anomaly present during development, known as a sequence, can be another
important factor influencing phenotypic expression [17]. For example, VCFS has been
reported to be the second most common genetic cause of Robin sequence [18], a well known
developmental sequence involving micrognathia or retrognathia, cleft palate, and upper
airway obstruction. It has been reported that approximately 11% of Robin sequence cases
are secondary to VCFS [18]. Both Potter sequence and holoprosencephaly sequence have
also been reported in individuals with VCFS [19,20]. Therefore, it is already known that
developmental sequences can be triggered by structural anomalies common to VCFS.
However, a broader analysis of large populations of individuals with VCFS has not assessed
relationships between phenotypes in a systematic manner.
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VCFS occurs with considerable variability of expression for nearly all of its clinical
features. This variability may be related to a combination of stochastic, environmental and
genetic influences. It is possible that examining the distribution of phenotypes in VCFS may
reveal patterns of co-occurring malformations that would suggest “field defects.” Such
patterns might help to guide the sorting of genome wide single nucleotide or copy number
polymorphisms in relation to phenotypes. Cardiovascular and craniofacial anomalies are
among the most common anomalies in humans and their association is seen in many
multiple anomaly syndromes. It has been hypothesized that both may be causally related to
hemizygosity of TBX1. The purpose of this paper is to determine if there are identifiable
relationships between craniofacial and cardiovascular malformations in VCFS. We report on
a retrospective chart review and statistical analysis of more than 300 subjects with VCFS
who have had careful phenotypic analysis to determine the associations between congenital
heart disease, palatal anomalies, and mandibular position.

Methods
Subjects
This retrospective chart review was reviewed and approved by the Institutional Review
Board (IRB #3669) at Upstate Medical University. The study sample included 316
Caucasian non-Hispanic subjects with VCFS ascertained from a larger racially mixed
sample. Only Caucasian non-Hispanic subjects were analyzed in this investigation to avoid
potential variability in facial phenotypes that might be related to racial variability. All cases
had deletions from 22q11.2 confirmed by fluorescence in situ hybridization or array
comparative genome hybridization analysis. Subjects were first entered into the study with
an age range of birth to sixty-five years. Nearly all subjects were seen at least three times by
Int J Pediatr Otorhinolaryngol. Author manuscript; available in PMC 2011 September 1.
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the examiners typically over a period of several years, and sometimes for a period of more
than thirty years. Clinical data were updated at the time of each examination. Data were
entered into a database that categorized all known phenotypes associated with the syndrome.
Evaluation
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All subjects were evaluated by the interdisciplinary team at the Velo-Cardio-Facial
Syndrome International Center at Upstate Medical University in Syracuse, New York. Data
obtained from the charts included direct physical examination, pediatric cardiology
assessment, heart ultrasound studies, endoscopic and fluoroscopic studies of the palate and
pharynx, laboratory results and radiographic imaging studies. Heart disease was classified
according to type based on echocardiograms or angiograms. Structure of the soft palate was
assessed by direct oral examination plus nasopharyngoscopy in all cases. Palatal anomalies
were labeled as either normal, overt cleft palate, submucous cleft palate, or occult
submucous cleft palate and asymmetry was also noted as previously described [9,21,22].
The category of submucous cleft palate was dependent on the presence of a bifid uvula in
association with muscle separation on the nasal surface of the palate as seen endoscopically
[9]. Occult submucous cleft palate was based on the presence of an intact uvula but muscle
separation on the nasal surface of the soft palate or absence of the musculus uvulae as seen
endoscopically [21]. Retrognathia was assessed by orthodontic evaluation based on
cephalometric and clinical exam that indicated a morphologically normal mandible by
measurement and comparison to age appropriate cephalometric norms with class II skeletal
malocclusion based on consensus agreement between the examining dentist and the last
author.
Data analysis
While each phenotypic feature was examined independently as a single category, some
cardiac and craniofacial anomalies were additionally analyzed as grouped variables. All
intra-cardiac and aortic arch defects were analyzed together. Intra-cardiac defects were
combined into a group to include tetrology of Fallot, ventricular septal defects, atrial septal
defects and truncus arteriosus. All variations of cleft palate were examined together as a
group, and aberrant right and left subclavian arteries were also examined as a group. The
associations between congenital heart disease and palatal anomalies were assessed
individually for each subtype by Chi Square analysis, or by Fisher Exact Test when any cell
value in the 2×2 table was less than eleven. Chi square analysis or Fisher Exact Test was
also performed for the association of retrognathia and palatal anomalies and the association
of heart anomalies with retrognathia.
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Results
No significant association was found for congenital heart disease and cleft palate or
congenital heart disease and retrognathia (Table 1). In fact, for all categories of associations,
no significant positive associations were found with the exception of occult submucous cleft
palate and retrognathia (Chi square = 18.959, nominal p= 0.000013) and submucous cleft
palate and retrognathia (Chi square = 4.57, nominal p= 0.0325). For overt cleft palate and
retrognathia, the Chi square = 0.022 and the p = 0.8821 [23]. After adjusting for the number
of comparisons assessed, only the association between occult submucous cleft palate and
retrognathia remained significant. The frequencies of phenotypic findings in our population
are detailed in Table 2.
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Heart anomalies, primarily conotruncal, have been reported to occur in approximately 70%
of individuals with VCFS and include intracardiac anomalies such as tetralogy of Fallot
(TOF), ventricular or atrial septal defects or persistent truncus arteriosus [24,25]. Major
aortic arch anomalies include interrupted aortic arch type B, double aortic arch, coarctation,
and right sided aortic arch. Pulmonic stenosis or atresia is also seen with frequency. VCFS is
known to constitute more than 50% of all cases of interrupted aortic arch type B, more than
50% of all cases of truncus arteriosus, and at least 15% of all cases of tetralogy of Fallot.
When right-sided aortic arch is present, the frequency of VCFS among individuals with TOF
is much higher [24]. The most common heart anomaly in individuals with VCFS is probably
ventricular septal defect, often of the malalignment type, with or without pulmonic stenosis
or atresia [26].
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The prevalence of congenital heart disease in our series diverges slightly from those reported
in previous studies, although in general the distribution is comparable [27]. Some lower
prevalence rates of cardiac findings such as TOF in our sample may be explained by a lower
ascertainment bias towards acute cardiac problems than in previous studies where detections
were made largely after referral for major heart anomalies. Subjects for this study were
ascertained through the Velo-Cardio-Facial Syndrome International Center in Syracuse, NY
where primary referrals for cardiac anomalies is not the primary reason for referral.
Referrals for feeding difficulties, speech impairment, behavioral and psychiatric concerns,
and developmental and educational problems are common in our sample. Many referrals are
made during pre-school and school age years after diagnosis had been made elsewhere, and
we have also seen many adults. It is likely that the referral base represents a broader
spectrum of the syndrome’s phenotypic expression and is more representative of the
population of people with VCFS.
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Structural palate anomalies are known to occur in approximately 70% of VCFS individuals.
Overt palatal clefts occur in 20% or fewer of the VCFS cases, with submucous cleft or
occult submucous cleft palate being far more common [10]. It has also been found that there
is a high frequency of palatal asymmetry in the individuals with VCFS [22]. Reports of the
association of congenital heart disease with cleft palate (without cleft lip) in the general
population have shown that slightly more than 10% of individuals with palatal anomalies
have congenital heart disease, but the number of VCFS cases among this 10% is unknown
[28]. Furthermore, it is unlikely that cases of occult submucous cleft were recognized in the
report of Geis et al. [28] because the concept and clinical findings of occult clefts were
initially reported at about the same time [21] and were not well understood at the time. The
association between a retruded mandible and palatal anomalies is well known in association
with Robin sequence, but has not been studied specifically in association with milder
variants of mandibular position, or milder variants of palatal anomalies, such as submucous
or occult submucous cleft palate.
Among all infants with cleft palate, the co-occurrence of congenital heart disease is more
frequent than would be expected by chance. Geis et al. [28] reported 10.24% frequency of
heart anomalies in individuals with clefts of the secondary palate including submucous cleft
and congenital palatal insufficiency (a term used to describe cases of occult submucous cleft
at that time) in a sample of 151. Shprintzen et al. [29] reported a 7% frequency of major
heart anomalies and 3% frequency of minor heart anomalies (such as patent ductus
arteriosus or patent foramen ovale) in a sample of 580 cases that included overt, submucous
and occult submucous clefts ascertained from a single craniofacial center. The association of
congenital heart disease with cleft palate (without cleft lip) by chance would be 1/272 (the
frequency of heart anomalies in the general population) [30] multiplied by 1/2000 live births
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with cleft palate (without cleft lip) which would calculate to a frequency of 1/544,000
[28,31]. Therefore, the high co-occurrence of these two anomalies indicates that they are
either somehow causally related or that they frequently have common causative factors.
Because VCFS has been reported to account for at least 5.0% [29,32] of all children at cleft
palate and craniofacial centers, it can be concluded that many of these occurrences are
related to this single syndrome. It would therefore be important to understand the underlying
causative factor in a syndrome with a known pathogenesis that may help to elucidate the
common causes of each of these clinical features.
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Because palatal anomalies and congenital heart disease occur together at such a high
frequency in VCFS, the causation must in some way be linked. It is possible that the
expression of the heart and craniofacial anomalies in VCFS are both caused by the
underexpression of a single gene because of hemizygosity. Using mouse and zebrafish
models, previous publications have demonstrated a probable causal relationship between the
deletion of TBX1 and the presence of congenital heart disease in humans with VCFS
[12,33,34]. Homozygous inactivation of TBX1 in mice has also yielded cleft palate,
mandibular hypoplasia, ear malformations, and low birth weight and length [12,33]. Cleft
palate and other craniofacial anomalies were not found in mice hemizygous for TBX1
deletions although outflow tract anomalies of the cardiovascular system were. In our sample,
the data demonstrate a lack of significant concordance between the presence of congenital
heart disease and cleft palate in 348 individuals with VCFS. Specifically, although both
anomalies occur frequently in the syndrome, in many instances palatal anomalies occur in
the absence of congenital heart disease, and conversely, congenital heart disease occurs
frequently in the absence of cleft palate. Therefore, the lack of significant association
between the effects of a hemizygous deletion of TBX1 on the human heart and on palatal
anomalies raises several important questions regarding the mechanism of expression for the
deletion. One possible explanation is that the effect of TBX1 is modified by genes outside of
the 22q11.2 region that may modulate the formation of either the palate or the heart [15,16].
Another possible explanation is that epigenetic factors may have an effect on genes within
the deleted region or modifying genes elsewhere. A third possible explanation is that TBX1
is not directly related to palate formation in humans although it may play a role in other
species. It is also possible that polymorphisms in the genes present on the normal copy of
choromosome 22 may provide some protection against certain malformations. The lack of
association, however, would seem to suggest that the presence of congenital heart disease
does not lead to the presence of palatal anomalies in a causative manner by developmental
sequence. In other words, it is unlikely that events related to perfusion and vascular supply
to the craniofacial complex cause structural anomalies of the palate.
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An analysis of the co-occurrence of retrognathia and congenital heart disease also revealed
no significant association although the homozygous mouse deleted for TBX1 showed
significant changes in mandibular structure. It has been reported that mandibular
morphology in VCFS is normal [35] and that only its position is different secondary to
platybasia and posterior positioning of the glenoid fossa and temporomandibular joint.
While the cause and possible genomic correlates of the abnormal skull base flexion in VCFS
have not been identified as yet, mandibular position could potentially relate to the
association of retrognathia with palate anomalies. For example, VCFS has been reported to
be the second most common genetic cause of Robin sequence [18], a developmental
sequence involving micrognathia, cleft palate, and upper airway obstruction. It has been
reported that approximately 11% of Robin sequence cases are secondary to VCFS [18].
Therefore, it is already known that structural anomalies can be causally linked in VCFS.
However, a broader analysis of large populations of individuals with VCFS has not assessed
relationships between phenotypes in a systematic manner and it is possible that a subset of
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genetic risk factors for craniofacial features combined with the deletion might also
contribute to the etiology and expression of Robin sequence.
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The only positive association between the phenotypes assessed in this study was that of
retrognathia and occult submucous cleft palate or submucous cleft palate. This finding
would seem to be contrary to the model of Robin sequence that postulates that posterior
positioning of the mandible results in the tongue being positioned high in the oral cavity
against the skull base at approximately 9 weeks post fertilization thereby preventing fusion
of the palatal shelves that are trying to migrate medially to form the hard and soft palate
[36–38]. There are several possible hypotheses that might be applicable, none of them being
mutually exclusive. First, since retrognathia in VCFS is related to an obtuse angulation of
the skull base, it is possible that cleft palate and retrognathia in VCFS have in common
certain develomental abrnomalities of skull morphology. Previous studies have
demonstrated that platybasia is a common finding in VCFS based on mid sagittal
radiographs, such as cephalometric images that have measured the skull base in 2
dimensions (the mid-sagittal plane) [35,39]. It is possible that the flattening of the skull base
may be part of or an initiating factor in other skull shape abnormalities, such as increased
width in addition to increased angulation. Such changes could alter the relationship of the
palate, maxilla, mandible, and the structures attached such as the pharynx and soft palate as
previously demonstrated by Arvystas and Shprintzen [35]. If the skull base were wider than
normal, this might make palatal fusion and migration of muscle tissue into the ectodermal
envelope of the palate more difficult. Although these alterations may not be sufficient to
cause overt clefting in all cases, it may be sufficient to prevent complete migration of
muscle tissue into the velar envelope. It has also been established that the muscle tissue of
the palate and pharynx is histologically abnormal; muscle fibers were found to be fewer in
number and thinner in diameter when compared to control samples [40]. It is therefore
possible that muscle migration is abnormal in terms of the amount of muscle mass available
to infiltrate the palatal envelope during embryogenesis. It is not known if this type of
primary muscle anomaly is related to TBX1, another gene deleted from the 22q11.2 locus, or
perhaps a downstream regulation of a gene elsewhere in the genome. Any or all of these
factors could be contributory.
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Another possible explanation for the association of retrognathia and cleft palate is that these
are primary anomalies associated with gene effect. Although it is not known if occult
submucous cleft palate represents a milder form of overt cleft palate, it is likely that this is
the case. It is therefore curious that retrognathia in VCFS is associated only with the mildest
form of structural palatal anomaly. The implication is that the overwhelming majority of
clefts are not associated with a developmental sequence (Robin sequence) but are rather
primary anomalies associated with gene action. Although Robin sequence occurs in a
percentage of VCFS cases, presumably the cases with the most severe retrognathia, and
VCFS constitutes a sizable percentage of Robin sequence cases, the total percentage of
Robin type clefts is small compared to the total sample of structural palatal anomalies.
Because retrognathia in VCFS is related to platybasia resulting in a posterior displacement
of the temporomandibular joint, it is possible that there is a major gene effect related to
cranial base formation and palatal formation that affects both. It is interesting to note that
clinically we find that relatively few of the overt clefts in VCFS involve the hard palate and
relatively few submucous clefts have notching of the posterior border of the hard palate. The
majority of the palatal anomalies in the syndrome are isolated to the velum. In future
phenotypic studies, it would be worthwhile to measure the width of the skull base in relation
to the presence of palatal anomalies to determine if there is a causal relationship.
As a result of careful phenotypic observation and analysis of a large sample of VCFS
subjects, we have shown that cardiac anomalies, palatal malformations, and mandibular
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anomalies do not seem to segregate together, but seem to vary in frequency independent of
each other. We also found that certain types of palatal clefts do appear to be associated with
the posterior displacement of the mandible in VCFS. Phenotypic correlation studies such as
this may serve as a guide for ongoing genetic studies and further studies to understand the
basis of these correlations. Additionally, this study points out the importance of keeping the
larger picture in mind when presented with a patient with VCFS, where a large number of
concerns may present that as of yet cannot be anticipated based on the presenting clinical
picture. Relatively little is currently known about the relationships between the other 190+
phenotypic presentations in VCFS, though using our clinical data we hope to continue
working to unmask the complex relationships between all of the various phenotypic
presentations in VCFS.
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sample size = 314
n=141
x2= 0.049
p= 0.8248
sample size= 305
n=23
p=1.0000
sample size= 294
n=6
p=0.1333
sample size= 286
n=8
p= 1.0000
sample size= 287
n=16
p= 1.0000
sample size= 287
n=20
p= 0.8059
sample size= 310
n=29
p= 0.2838
sample size= 309
n=17
p= 0.3195
sample size= 309
n=8
p= 0.1901
sample size= 309
n=21
p= 0.8090
sample size= 310
n=33
p= 0.8465
sample size= 307

Any Heart Defect (intracardiac or aortic arch)

Pulmonary Atresia/Stenosis

Vascular Ring

Aberrant LSC

Aberrant RSC

Any Aberrant SC

Right Sided AA

IAA Type B

Truncus

PDA

TOF

VSD

Any Cleft Palate
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sample size= 310

sample size= 313
n=6
p= 0.2413

sample size= 312
n=4
p= 0.2529

sample size= 312
n=0
p= 0.6163

sample size= 312
n=3
p=0.4798

sample size= 313
n=3
p= 1.0000

sample size= 290
n=2
p= 1.0000

sample size= 290
n=2
p= 0.6969

sample size= 289
n=1
p= 1.0000

sample size= 297
n=1
p=1.0000

sample size= 308
n=3
p=0.7519

sample size= 317
n= 19
p= 0.3059

Overt Cleft Palate

sample size= 309

sample size= 312
n=10
p= 0.2895

sample size= 311
n=9
p= 0.6593

sample size= 311
n=4
p= 1.0000

sample size= 311
n=8
p= 1.0000

sample size= 312
n=11
x2= 0.002
p= 0.9643

sample size= 289
n=7
p= 0.6643

sample size= 289
n=4
p= 0.3232

sample size= 288
n=3
p= 1.0000

sample size= 296
n=1
p=0.1126

sample size= 307
n=10
p=0.8404

sample size= 316
n=54
x2= 0.713
p=0.3984

Submucous Cleft Palate

sample size= 306

sample size= 309
n=18
x2= 0.586
p= 0.4439

sample size= 308
n=8
p= 0.5295

sample size= 308
n=4
p= 0.7727

sample size= 308
n=6
p= 0.1973

sample size= 309
n=15
x2= 0.856
p= 0.3548

sample size= 286
n=11
x2= 0.251
p= 0.6164

sample size= 286
n=10
p= 0.3396

sample size= 285
n=4
p= 1.0000

sample size= 293
n=4
p= 1.0000

sample size= 304
n=10
p=0.8415

sample size= 313
n=70
x2= 0.022
p=0.8820

Occult Submucous Cleft Palate

sample size= 271

sample size= 274
n=16
x2= 0.6
p= 0.4386

sample size= 273
n=10
p= 1.0000

sample size= 273
n=7
p= 0.3387

sample size= 271
n=14
p= 0.1796

sample size= 271
n=17
x2= 0.111
p= 0.7390

sample size= 251
n=14
x2= 0.055
p= 0.8146

sample size= 251
n=11
p=0.6266

sample size= 250
n=6
p= 1.0000

sample size= 257
n=6
p= 0.7534

sample size= 267
n=15
x2= 0.319
p=0.5722

sample size= 274
n=86
x2= 2.275
p=0.1315

Retrognathia

Correlations between cardiac, cleft and mandibular phenotypes. [Note: Reported p-values are not adjusted to account for the number of statistical tests
run.]
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sample size= 312
n=118
x2= 0.554
p= 0.4567
sample size= 276
n=121
x2= 6.644
p= 0.00995

Retrognathia

sample size= 309
n=25
x2= 2.886
p= 0.0894

sample size= 276
n=12
x2= 0.022
p= 0.8821

sample size= 315
n=17
x2= 1.21
p= 0.2713

sample size= 312
n=3
p= 1.0000

n=10
p= 0.5075

Intracardiac (Truncus, TOF, VSD, or ASD)

ASD

Overt Cleft Palate
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n=71
x2= 0.667
p= 0.4141

sample size= 276
n=37
x2= 4.574
p= 0.0325

sample size= 314
n=46
x2= 0.511
p= 0.4747

sample size= 311
n=13
x2= 0.204
p= 0.6515

n=26
x2= 1.031
p= 0.3099

Submucous Cleft Palate

sample size= 275
n=73
x2= 18.959
p= 0.000013

sample size= 311
n=57
x2= 0.134
p= 0.7143

sample size= 308
n=9
p= 0.0731

n=36
x2= 0
p= 1.0000

Occult Submucous Cleft Palate

sample size= 274
n=74
x2= 1.506
p= 0.2198

sample size= 272
n=15
x2= 0.003
p= 0.9563

n=52
x2= 5.042
p= 0.0247

Retrognathia
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Table 2

Frequency of Phenotypes

NIH-PA Author Manuscript

Phenotype

NIH-PA Author Manuscript

Sample size

% with phenotype

Any Heart Defect (Intracardiac or Aortic Arch)

327

59.33%

Intracardiac Defect (Truncus, TOF, ASD, VSD)

324

50.31%

Truncus

321

4.36%

PDA

321

8.10%

TOF

322

14.29%

ASD

321

12.15%

VSD

319

30.72%

IAA Type B

320

7.81%

Right Sided Aortic Arch

321

11.21%

Coarctation of the Aorta

320

1.56%

Double Aortic Arch

318

0.94%

Any Aberrant Subclavian

297

9.43%

Aberrant Right Subclavian

297

7.07%

Aberrant Left Subclavian

296

3.72%

Pulmonary Atresia/Stenosis

316

10.44%

Vascular Ring

304

3.95%

Any Cleft Palate

327

77.37%

Overt Cleft Palate

330

9.09%

Submucous Cleft Palate

329

30.70%

Occult Submucous Cleft Palate

326

37.42%

Retrognathia

278

51.44%
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